Employees: 11 (2023.0)Legal category: 5485Size: PMECreation date: 2015-01-21 (11 years)Status: ActiveBusiness sector: Commerce de détail de produits pharmaceutiques en magasin spécialiséLocation: MONTPELLIER (34070), Herault
Les données financières de cette entreprise sont partiellement disponibles (liasse simplifiée ou données confidentielles). Certaines sections ne sont pas affichées.
PHARMA MC : revenue, balance sheet and financial ratios
PHARMA MC is a French company
founded 11 years ago,
specialized in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé.
Based in MONTPELLIER (34070),
this company of category PME
shows in 2024 a net income positive of 64 k€.
Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.
In 2024, PHARMA MC generates positive net income of 64 k€. Net income represents the final profit after all expenses (operating, financial, exceptional) and corporate tax. Change over 2016-2024: 148 k€ -> 64 k€.
Net income (2024)
?
Net income
Definition
Profit or loss after all expenses, including taxes and exceptional items.
Formula
Current income + Exceptional income - Income tax
64 186 €
Loading income statement...
Income statement
Item
Amount
% Revenue
Change
The detailed income statement is not available for this company (simplified accounts or confidential data).
Chart evolution
Show :
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Assets
Loading data...
Item
Gross
Deprec.
Net
%
Change
Assets balance sheet data not available for this company
Liabilities
Loading data...
Item
Year
%
Change
Liabilities balance sheet data not available for this company
Solvency and debt ratios
The debt ratio (= Financial debt / Equity x 100) stands at 39%. Debt remains under control: the company retains capacity to raise new debt if needed. Financial autonomy (= Equity / Total assets x 100) reaches 52%. This high autonomy means the company finances most of its assets through equity, a sign of strength.
Debt ratio (2024)
?
Debt ratio
Definition
Measures the proportion of debt to equity.
Formula
(Financial debt / Equity) x 100
Interpretation
< 50% : Low 50-100% : Moderate > 100% : High
39.322%
Financial autonomy (2024)
?
Financial autonomy
Definition
Share of equity in the company's total financing.
Formula
(Equity / Total assets) x 100
Interpretation
> 30% : Good autonomy 20-30% : Average < 20% : Low
51.93%
Asset age ratio (2024)
?
Asset age ratio
Definition
Measures the degree of wear of tangible assets.
Formula
Accumulated depreciation / Gross fixed assets x 100
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Indicator
2016
2017
2018
2019
2020
2021
2022
2023
2024
Debt ratio
247.744
194.035
152.338
120.122
86.779
59.779
42.153
53.629
39.322
Financial autonomy
25.057
26.48
32.623
38.076
43.016
51.53
54.962
49.856
51.93
Repayment capacity
None
None
None
None
None
None
None
None
None
Cash flow / Revenue
None%
None%
None%
None%
None%
None%
None%
None%
None%
Sector positioning
Debt ratio
39.322024
2022
2023
2024
Q1: 16.46
Med: 58.48
Q3: 154.77
Good
In 2024, the debt ratio of PHARMA MC (39.32) ranks below the median of the sector. This ratio measures the weight of debt relative to equity. This controlled position reflects prudent management.
Financial autonomy
51.93%2024
2022
2023
2024
Q1: 28.91%
Med: 49.95%
Q3: 69.47%
Good-8 pts over 3 years
In 2024, the financial autonomy of PHARMA MC (51.9%) ranks above the median of the sector. This ratio represents the share of equity in total financing. This comfortable position offers an appreciable safety margin.
Liquidity ratios
The liquidity ratio (= Current assets / Current liabilities) stands at 134.53. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months.
Liquidity ratio (2024)
?
Liquidity ratio
Definition
Ability to meet short-term debts with current assets.
Formula
Current assets / Current liabilities
Interpretation
> 1.5 : Very good 1-1.5 : Fair < 1 : Liquidity risk
134.532
Liquidity indicators evolution PHARMA MC
Visualisation créée via abddaf.fr Sources : INPI & BCE - Retraitements : Ministère de l'économie
Indicator
2016
2017
2018
2019
2020
2021
2022
2023
2024
Liquidity ratio
254.189
163.342
183.025
188.648
175.473
204.512
186.895
151.318
134.532
Interest coverage
None
None
None
None
None
None
None
None
None
Sector positioning
Liquidity ratio
134.532024
2022
2023
2024
Q1: 129.46
Med: 182.14
Q3: 260.79
Average-17 pts over 3 years
In 2024, the liquidity ratio of PHARMA MC (134.53) ranks below the median of the sector. This ratio measures the ability to cover short-term debt with current assets. An improvement would strengthen the competitive position.
Positioning of PHARMA MC in its sector
Comparison with sector Commerce de détail de produits pharmaceutiques en magasin spécialisé
Valuation estimate
Based on 225 transactions of similar company sales
in 2024,
the value of PHARMA MC is estimated at
896 084 €
(range 624 018€ - 1 340 592€).
This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate.
Estimated enterprise value2024
225 transactions
624k€896k€1340k€
896 084 €Range: 624 018€ - 1 340 592€
NAF 5 année 2024
Valuation method used
Net Income Multiple
64 186 €
×
14.0x
=896 084 €
Range: 624 019€ - 1 340 593€
Only this financial indicator is available for this company.
Valuation evolution
Visualisation creee via abddaf.fr Sources : BODACC & INPI
How is this estimate calculated?
This estimate is based on the analysis of 225 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.
EBITDA Multiple: Preferred method for profitable SMEs. EBITDA reflects the ability to generate cash.
Revenue Multiple: Used for growing companies or those with low profitability. Reflects commercial potential.
Net Income Multiple: Relevant for mature companies with stable results.
This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).
Similar companies (Commerce de détail de produits pharmaceutiques en magasin spécialisé)
Compare PHARMA MC with other companies in the same sector:
The revenue of PHARMA MC is not publicly disclosed (confidential accounts filed with INPI).
Is PHARMA MC profitable?
Yes, PHARMA MC generated a net profit of 64 k€ in 2024.
Where is the headquarters of PHARMA MC ?
The headquarters of PHARMA MC is located in MONTPELLIER (34070), in the department Herault.
Where to find the tax return of PHARMA MC ?
The tax return of PHARMA MC is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).
In which sector does PHARMA MC operate?
PHARMA MC operates in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé (NAF code 47.73Z). See the 'Sector positioning' section above to compare the company with its competitors.
Item evolution
Rotate your phone to landscape mode to view the chart